Overexpression of Karyopherin-2 in Epithelial Ovarian Cancer and Correlation With Poor Prognosis
- 1 October 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 116 (4), 884-891
- https://doi.org/10.1097/aog.0b013e3181f104ce
Abstract
OBJECTIVES: To evaluate karyopherin 2 (KPNA2) as a biomarker for epithelial ovarian cancer. METHODS: A candidate oncogene, KPNA2, was identified in gene microarray assays of epithelial ovarian cancer tissues compared with normal human ovarian surface epithelial tissues. Differences in expression were further validated by real-time polymerase chain reaction and Western blotting. KPNA2 expression patterns in epithelial ovarian cancer tissues were determined using immunohistochemistry and were compared with specific clinicopathologic features of the patient specimens analyzed. Factors associated with patient survival were also statistically analyzed. RESULTS: KPNA2 was found to be upregulated approximately eightfold in epithelial ovarian cancer tissues compared with human ovarian surface epithelial tissues, and overexpression was detected at the level of both transcription and translation. Immunohistochemical assays detected positive KPNA2 expression (++ or +++) in 50 of 102 (49.0%) epithelial ovarian cancer specimens, whereas negative KPNA2 expression (− or +) was observed in all of the human ovarian surface epithelial tissues analyzed. KPNA2 overexpression was also found to be significantly associated with specific histologic type, an advanced stage, a high histologic grade, and tumor recurrence (P<.05). The 5-year overall survival rate for KPNA2-negative compared with KPNA2-positive patients was 73.1% and 60.5%, respectively (P<.05). CONCLUSION: KPNA2 may play an important role in the development, differentiation, and carcinogenesis of epithelial ovarian cancer and therefore could be an indicator of poor prognosis for patients with epithelial ovarian cancer. LEVEL OF EVIDENCE: IIKeywords
This publication has 25 references indexed in Scilit:
- Treatment of recurrent epithelial ovarian cancerTherapeutics and Clinical Risk Management, 2009
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian CancerCancer Research, 2008
- Function of Both Sinusoidal and Canalicular Transporters Controls the Concentration of Organic Anions within HepatocytesMolecular Pharmacology, 2007
- Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast CancerClinical Cancer Research, 2006
- Bmi-1 Is a Novel Molecular Marker of Nasopharyngeal Carcinoma Progression and Immortalizes Primary Human Nasopharyngeal Epithelial CellsCancer Research, 2006
- Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve PrognosisJNCI Journal of the National Cancer Institute, 2006
- Dissection of the Karyopherin α Nuclear Localization Signal (NLS)-binding GrooveJournal of Biological Chemistry, 2003
- Genomic structure of karyopherin ?2 ( KPNA2 ) within a low-copy repeat on chromosome 17q23-q24 and mutation analysis in patients with Russell-Silver syndromeHuman Genetics, 2001
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958